Zobrazeno 1 - 10
of 566
pro vyhledávání: '"Drug-induced hepatitis"'
Publikováno v:
Jurnal Respirasi, Vol 10, Iss 3, Pp 214-221 (2024)
Introduction: Drug-induced hepatitis (DIH) is one of the serious side effects of anti-tuberculosis drugs (ATD) that can reduce patient compliance with tuberculosis (TB) treatment, increase the risk of treatment failure, or develop drug resistance. Vi
Externí odkaz:
https://doaj.org/article/e445fe74d40a4e18986462a7e9f49c78
Autor:
Jawaher J. Alotaibi, Bushra Albuqami, Wadha Alotaibi, Rawan M. Al Ghamdi, Mohammed Alaskar, Hadi Kuriry, Nasser Almasri
Publikováno v:
Clinical Case Reports, Vol 12, Iss 4, Pp n/a-n/a (2024)
Abstract This report described a patient not known to have a hepatic disease, found to have a drug‐induced autoimmune hepatitis from denosumab. This is an unreported side effect, and here, we presented the possible predisposing factors and suggeste
Externí odkaz:
https://doaj.org/article/9a14bbed0cc24d6da32f316688a5f681
Autor:
Likić-Lađević Ivana, Petronijević Miloš, Vrzić-Petronijević Svetlana, Beleslin Aleksandra, Dugalić Stefan
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 152, Iss 1-2, Pp 85-87 (2024)
Introduction. There are three groups of disorders during pregnancy: disorders specific for pregnancy that resolve spontaneously or soon after delivery, acute hepatic disorders coinciding with pregnancy, and chronic disorders. Drug-induced liver disea
Externí odkaz:
https://doaj.org/article/bc21bc0e19494059b433b91e94ba605f
Publikováno v:
Gastroenterologìa, Vol 57, Iss 2, Pp 90-95 (2023)
Background. The aim of the study is to analyze the parameters of liver steatosis and fibrosis based on shear wave elastography (SWE) and steatometry data in patients with chronic diffuse liver diseases, taking into account the etiological factor, and
Externí odkaz:
https://doaj.org/article/19f72a303afd464d9f7a2f01dea908b0
Publikováno v:
Medičnì Perspektivi, Vol 27, Iss 4, Pp 100-114 (2022)
The aim of our research was to obtain new minimally invasive serum markers of fibrotic changes of liver in patients with chronic diffuse liver diseases of different etiology and compare them with traditional markers. 364 patients aged 30 to 66 years
Externí odkaz:
https://doaj.org/article/bcb4aa02154747cc99d50ff6f02516bb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Gastroenterologìa, Vol 55, Iss 2, Pp 91-97 (2021)
Background. In recent years, as a result of the growing expansion of the pharmaceutical market, there has been a clear trend towards an increase in the incidence of chronic toxic drug-induced hepatitis of drug genesis (TDIH). The appearance of fibros
Externí odkaz:
https://doaj.org/article/5457ba312578488fb347364b100ebb09
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 76-83 (2021)
The pandemic of COVID-19 is changing the usual clinical practice. Most of the drugs used for the etiotropic and pathogenetic therapy of COVID-19 do not have a sufficient evidence base, approaches to therapy of liver, gastrointestinal tract and other
Externí odkaz:
https://doaj.org/article/4e9d3debaac243afa1d7bea347f55e5a
Publikováno v:
Clinical Case Reports, Vol 10, Iss 4, Pp n/a-n/a (2022)
Abstract We report a case of probable norethisterone‐related liver injury, manifesting as a significant rise in liver transaminases in a 62‐year‐old woman. Upon discontinuation of norethisterone, liver transaminases decreased to normal level wi
Externí odkaz:
https://doaj.org/article/9d07b0ba7014479c9eebf744e317255e
Publikováno v:
Virology Journal, Vol 17, Iss 1, Pp 1-8 (2020)
Abstract Background This study was conducted to estimate the prevalence, determinants of hepatitis B, hepatitis C and the survival of tuberculosis patients until drug-induced hepatitis. Methods Prospective cohort study design was implemented. The dat
Externí odkaz:
https://doaj.org/article/b41749423ef04f0284382a0d8bb73552